Variants Affecting the C-Terminal Tail of UNC93B1 Are Not a Common Risk Factor for Systemic Lupus Erythematosus.
Sarah KienerCamillo RibiIrene KellerCarlo ChizzoliniMarten TrendelenburgUyen Huynh-DoJohannes von Kempisnull On Behalf Of Swiss Sle Cohort Study SscsTosso LeebPublished in: Genes (2021)
Systemic lupus erythematosus (SLE) is a heterogeneous multifactorial disease. Upregulated TLR7 signaling is a known risk factor for SLE. Recently, it was shown that specific genetic variants in UNC93B1 affect the physiological regulation of TLR7 signaling and cause characteristic autoimmune phenotypes with monogenic autosomal recessive inheritance in mutant mice and dogs. We therefore hypothesized that homologous variants in the human UNC93B1 gene might be responsible for a fraction of human SLE patients. We analyzed 536 patients of the Swiss SLE Cohort Study for the presence of genetic variants affecting the C-terminal tail of UNC93B1. None of the investigated patients carried bi-allelic UNC93B1 variants that were likely to explain their SLE phenotypes. We conclude that genetic variants affecting the C-terminal tail of UNC93B1 are not a common risk factor for SLE. It cannot be excluded that such variants might contribute to other heritable autoimmune diseases.
Keyphrases
- systemic lupus erythematosus
- disease activity
- end stage renal disease
- ejection fraction
- newly diagnosed
- copy number
- prognostic factors
- rheumatoid arthritis
- toll like receptor
- endothelial cells
- type diabetes
- gene expression
- oxidative stress
- dna damage
- mitochondrial dna
- dna methylation
- mass spectrometry
- genome wide
- insulin resistance
- high resolution
- metabolic syndrome
- dna repair
- induced pluripotent stem cells
- wild type